Clinical Study

Impact of Dabigatran versus Phenprocoumon on ADP Induced Platelet Aggregation in Patients with Atrial Fibrillation with or without Concomitant Clopidogrel Therapy (the Dabi-ADP-1 and Dabi-ADP-2 Trials)

Figure 4

Platelet aggregation in patients with dabigatran and phenprocoumon therapy treated concomitantly with clopidogrel at 14 days (Dabi-ADP-2). Box plot analyses of multiple electrode platelet aggregometry (MEA) measurements for (a) ADP, (b) ADPtest HS, (c) TRAP, and (d) COL induced platelet aggregation in patients with either dabigatran (, blue) versus phenprocoumon (, red). Boxes indicate 25th and 75th percentiles and whiskers denote 10th and 90th percentiles.
(a)
(b)
(c)
(d)